Pharma Monopoly: The Battle for the Future of Medicines
admin The confrontation between United States Senator John Cornyn and AbbVie CEO Richard Gonzalez during a...
Health
Eli Lilly to buy three small vaccine developers
The financial engine driving this aggressive M&A strategy is no secret. Eli Lilly is currently...
Humor as a Scalpel: Will Flanary on the Front Lines of Medical Advocacy and the Ethics of Digital Influence
Will Flanary, an Oregon-based ophthalmologist, has spent the last decade navigating a dual existence. In...
The CDC’s Diminished Role in Global Health: Analyzing the Hantavirus Outbreak Response.
The typical hallmarks of a federal response to a burgeoning international health crisis were conspicuously...
The Long-Awaited Breakthrough in Pancreatic Cancer: How Targeting the ‘Undruggable’ KRAS Mutation is Changing Lives.
Leanna Stokes had gotten into the habit of asking her oncologist what might be next...
Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role
The relief stems largely from Schwartz’s resume, which stands in stark contrast to some of...
Trump Issues Landmark Executive Order to Fast-Track Psychedelic Therapies for Mental Health Crisis
WASHINGTON — In a move that marks a significant departure from decades of federal drug...
Bridging the Great Divide: How Long-Form Dialogue is Navigating the Crisis of Trust in Public Health
The landscape of American public health is currently undergoing a seismic shift, characterized by a...
A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Patients with advanced pancreatic adenocarcinoma who were treated with the company’s daily pill called daraxonrasib...
Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
A group of researchers led by Richard DiMarchi and Matthias Tschöp—two of the most decorated...